Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

被引:0
|
作者
Andrew S. Chi
Rohinton S. Tarapore
Matthew D. Hall
Nicole Shonka
Sharon Gardner
Yoshie Umemura
Ashley Sumrall
Ziad Khatib
Sabine Mueller
Cassie Kline
Wafik Zaky
Soumen Khatua
Shiao-Pei Weathers
Yazmin Odia
Toba N. Niazi
Doured Daghistani
Irene Cherrick
David Korones
Matthias A. Karajannis
Xiao-Tang Kong
Jane Minturn
Angela Waanders
Isabel Arillaga-Romany
Tracy Batchelor
Patrick Y. Wen
Krystal Merdinger
Lee Schalop
Martin Stogniew
Joshua E. Allen
Wolfgang Oster
Minesh P. Mehta
机构
[1] NYU Langone Health and School of Medicine,Radiation Oncology
[2] Oncoceutics,undefined
[3] Miami Cancer Institute,undefined
[4] Nicklaus Children’s Hospital,undefined
[5] University of Nebraska Medical Center,undefined
[6] University of Michigan,undefined
[7] Levine Cancer Institute,undefined
[8] University of California,undefined
[9] San Francisco,undefined
[10] M.D. Anderson Cancer Center,undefined
[11] SUNY Upstate Medical University,undefined
[12] University of Rochester,undefined
[13] Memorial Sloan Kettering Cancer Center,undefined
[14] University of California,undefined
[15] Childrens Hospital of Philadelphia,undefined
[16] Massachusetts General Hospital,undefined
[17] Dana-Farber/Brigham and Women’s Cancer Center,undefined
来源
Journal of Neuro-Oncology | 2019年 / 145卷
关键词
Pediatric; Adult; Glioma; DRD2 antagonist; ONC201; H3 K27M; Radiation; Diffuse midline; Diffuse intrinsic pontine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:97 / 105
页数:8
相关论文
共 50 条
  • [21] Single agent activity of ONC201 in non-midline H3 K27M-mutant diffuse gliomas.
    Odia, Yazmin
    Sumrall, Ashley Love
    Cloughesy, Timothy Francis
    Nghiemphu, Phioanh Leia Leia
    Hall, Matthew David
    Daghistani, Doured
    Mehta, Minesh P.
    Lassman, Andrew B.
    Arrillaga-Romany, Isabel
    Gardner, Sharon L.
    Tarapore, Rohinton
    Lu, Guangrong
    Allen, Joshua E.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] INDOLENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA
    Damodharan, Sudarshawn
    Bradley, Kristin
    Stadler, Andrew
    Rebsamen, Susan
    Helgager, Jeffrey
    Puccetti, Diane
    NEURO-ONCOLOGY, 2022, 24 : 24 - 24
  • [23] A case of diffuse midline glioma, H3 K27M-mutant
    Kyriakopoulos, G.
    Anagnostopoulos, C.
    Boskos, C.
    Korfias, S.
    Stranjalis, G.
    Razis, E.
    Argyrakos, T.
    VIRCHOWS ARCHIV, 2017, 471 : S219 - S219
  • [24] ONC108: A RANDOMIZED PHASE 3 STUDY OF ONC201 IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA
    Arrillaga-Romany, Isabel
    Lassman, Andrew
    McGovern, Susan
    Mueller, Sabine
    Nabors, L. Burt
    van den Bent, Martin
    Vogelbaum, Michael
    Allen, Joshua E.
    Melemed, Allen
    Tarapore, Rohinton
    Yang, Dewen
    Wen, Patrick Y.
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2022, 24 : 249 - 249
  • [25] PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG
    Gardner, Sharon
    Tarapore, Rohinton
    Allen, Jeffrey
    Zaky, Wafik
    Odia, Yazmin
    Hall, Matthew
    Daghistani, Doured
    Khatib, Ziad
    Koschmann, Carl
    Aguilera, Dolly
    MacDonald, Tobey
    Fouladi, Maryam
    McGovern, Susan
    Merdinger, Krystal
    Oster, Wolfgang
    Allen, Joshua
    Khatua, Soumen
    NEURO-ONCOLOGY, 2019, 21 : 185 - 185
  • [26] PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG
    Gardner, Sharon
    Tarapore, Rohinton
    Allen, Jeffrey
    Zaky, Wafik
    Odia, Yazmin
    Hall, Matthew
    Daghistani, Doured
    Khatib, Ziad
    Koschmann, Carl
    Aguilera, Dolly
    MacDonald, Tobey
    Fouladi, Maryam
    McGovern, Susan
    Kline, Cassie
    Vitanza, Nicholas
    Lu, Guangrong
    Merdinger, Krystal
    Oster, Wolfgang
    Allen, Joshua
    Khatua, Soumen
    NEURO-ONCOLOGY, 2020, 22 : 297 - 297
  • [27] ACTION: A randomized phase 3 study of dordaviprone (ONC201) in patients with newly diagnosed H3 K27M-mutant diffuse glioma
    Arrillaga-Romany, Isabel
    Lassman, Andrew
    McGovern, Susan L.
    Mueller, Sabine
    Nabors, Louis B.
    Van den Bent, Martin
    Vogelbaum, Michael
    Allen, Joshua E.
    Melemed, Allen S.
    Tarapore, Rohinton S.
    Yang, Dewen
    Wen, Patrick
    Cloughsey, Timothy
    CANCER RESEARCH, 2023, 83 (08)
  • [28] Clinicopathological analysis of diffuse midline glioma, H3 K27M-mutant
    Kim, Seong-Ik
    Lee, Yujin
    Won, Jae Kyung
    Park, Sung-Hye
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (06): : 517 - 517
  • [29] SAFETY OF ONC201 ADMINISTERED TWO CONSECUTIVE DAYS PER WEEK IN PEDIATRIC H3 K27M-MUTANT GLIOMA PATIENTS
    Gardner, Sharon
    Koschmann, Carl
    Tarapore, Rohinton
    Allen, Jeffrey
    Zaky, Wafik
    Odia, Yazmin
    Hall, Matthew
    Daghistani, Doured
    Khatib, Ziad
    Aguilera, Dolly
    MacDonald, Tobey
    de Blank, Peter
    McGovern, Susan
    Mueller, Sabine
    Kline, Cassie
    Vitanza, Nicholas
    Allen, Joshua
    Khatua, Soumen
    NEURO-ONCOLOGY, 2021, 23 : 67 - 67
  • [30] Diffuse Midline Glioma, H3 K27M-Mutant: A Case Report
    Rodriguez Leon, Jose
    Perez Berenguer, Juan
    Morales Vargas, Bryan
    Rivera Roman, Keila
    Vigo Prieto, Juan
    Labat Alvarez, Eduardo
    Ferrer Torres, Luis
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S34 - S34